Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a Mexican national immunization day

Journal of Clinical Microbiology

Volumn 49, Issue 5, 2011, Pages 1777-1783

  Troy, Stephanie B ^a   Ferreyra Reyes, Leticia ^b   Huang, ChunHong ^a   Mahmud, Nadim ^a   Lee, Yu Jin ^a   Canizales Quintero, Sergio ^b   Flaster, Harry ^a   Báez Saldaña, Renata ^b   García García, Lourdes ^b   Maldonado, Yvonne ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

5' UNTRANSLATED REGION; ACCURACY; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DETERMINATION; FECES ANALYSIS; HUMAN; INFANT; INTERMETHOD COMPARISON; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLIOMYELITIS VIRUS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CLEAVAGE; REAL TIME POLYMERASE CHAIN REACTION; REVERTANT; RNA EXTRACTION; SEROTYPE; SEWAGE; VIRUS SHEDDING;

FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEXICO; MUTATION; POLIOVIRUS; POLIOVIRUS VACCINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEWAGE; VIROLOGY; VIRULENCE; VIRUS SHEDDING;

POLIOVIRUS;

EID: 79955536364     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02524-10     Document Type: Article

References (19)

1. Anonymous. 2010. Progress toward interruption of wild poliovirus transmission - worldwide, 2009. MMWR Morb. Mortal. Wkly. Rep. 59:545-550.
2. Asturias, E., et al. 2007. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J. Infect. Dis. 196:692-698.
3. Corless, C., et al. 2002. Development and evaluation of a 'real-time' RT-PCR for the detection of enterovirus and parechovirus RNA in CSF and throat swab samples. J. Med. Virol. 67:555-562.
4. Gnanashanmugam, D., et al. 2007. Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay. J. Clin. Microbiol. 45:2419-2425.
5. Huang, Q., et al. 2005. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet 366:394-396. (Pubitemid 41073958)
6. Jenkins, H., et al. 2010. Implications of a circulating vaccine-derived polio-virus in Nigeria. N. Engl. J. Med. 362:2360-2369.
7. Kilpatrick, D. R., et al. 2009. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J. Clin. Microbiol. 47:1939-1941.
8. Laassri, M., et al. 2005. Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J. Clin. Microbiol. 43:2886-2894.
9. Laassri, M., et al. 2005. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J. Infect. Dis. 192:2092-2098.
10. Li, B., I. Kadura, D. Fu, and D. Watson. 2004. Genotyping with TaqMAMA. Genomics 83:311-320. (Pubitemid 38050119)
11. Mallet, L., et al. 1997. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells. J. Med. Virol. 52:50-60.
12. Martinez, C., et al. 2004. Shedding of Sabin poliovirus type 3 containing the nucleotide 472 uracil-to-cytosine point mutation after administration of oral poliovirus vaccine. J. Infect. Dis. 190:409-416.
13. Más Lago, P., et al. 2003. Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba. Int. J. Epidemiol. 32:772-777.
14. Minor, P. 2009. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine 27:2649-2652.
15. Minor, P., A. Macadam, D. Stone, and J. Almond. 1993. Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Biologicals 21:357-363. (Pubitemid 24106891)
16. ProMexico. 2010, posting date. Negocios. Birmex: The Mexican Health Company, Mexico DF, Mexico. http://negocios.promexico.gob.mx/english/02-2010/ art05.html.
17. Walters, S., K. Yamahara, and A. Boehm. 2009. Persistence of nucleic acid markers of health-relevant organisms in seawater microcosms: implications for their use in assessing risk in recreational waters. Water Res. 43:4929-4939.
18. WHO. 22 March 2011, posting date. Circulating vaccine-derived poliovirus (cVDPV) 2000-2011. World Health Organization, Geneva, Switzerland. www.globalpolioeradication.org/dataandmonitoring/poliothisweek /circulatingvaccinederivedpoliovirus.aspx.
19. WHO. 2004. Polio laboratory manual, 4th ed. Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland.